...
首页> 外文期刊>Journal of Virological Methods >Rapid genotyping of carcinogenic human papillomavirus by loop-mediated isothermal amplification using a new automated DNA test (Clinichip HPV (TM))
【24h】

Rapid genotyping of carcinogenic human papillomavirus by loop-mediated isothermal amplification using a new automated DNA test (Clinichip HPV (TM))

机译:使用新型自动DNA测试(Clinichip HPV(TM)),通过环介导的等温扩增,快速对致癌性人乳头瘤病毒进行基因分型

获取原文
获取原文并翻译 | 示例
           

摘要

This study was designed to evaluate the Clinichip HPV test, a new DNA test that detects carcinogenic human papillomavirus (HPV) rapidly by loop-mediated isothermal amplification and performs genotyping of all 13 carcinogenic types using automated DNA chip technology with an assay time 2.5 h. Using this test, 247 Japanese women (109 with normal cytology, 43 with cervical intraepithelial neoplasia grade 1, 60 with cervical intraepithelial neoplasia grade 2/3 and 35 with invasive cervical cancer) were tested for carcinogenic HPV genotypes. The results were compared to those obtained by the polymerase chain reaction-amplified DNA sequencing using 13 type-specific primers. Overall, there was very good agreement for the detection of carcinogenic HPV between the Clinichip test and direct sequencing, with 95.5% total agreement and a kappa value of 0.91. Comparison of the detection of individual HPV types shows that the overall agreement was also high (range: 96.8-100%). In women with cervical intraepithelial neoplasia grade 2 or worse, the detection rate of carcinogenic HPV was 95.7% by both the Clinichip test and the direct-sequencing method, indicating complete agreement between the two methods. In conclusion, it was found that the Clinichip test is a promising new laboratory method for genotyping of carcinogenic HPV
机译:这项研究旨在评估Clinichip HPV测试,这项新的DNA测试通过环介导的等温扩增快速检测致癌的人乳头瘤病毒(HPV),并使用自动DNA芯片技术对所有13种致癌类型进行基因分型,分析时间为2.5 h。使用该测试,对247位日本女性(109位细胞学正常,43位1级宫颈上皮内瘤变,60位2/3级宫颈上皮内瘤变和35位浸润性宫颈癌)进行了致癌性HPV基因型测试。将结果与使用13种类型特异性引物通过聚合酶链反应扩增的DNA测序获得的结果进行比较。总体而言,在Clinichip测试和直接测序之间,对于致癌性HPV的检测非常一致,总一致性为95.5%,κ值为0.91。比较单个HPV类型的检测结果表明,总体一致性也很高(范围:96.8-100%)。在Clinichip试验和直接测序法中,宫颈上皮内瘤变2级或更严重的女性中,致癌性HPV的检出率为95.7%,表明这两种方法之间完全吻合。总之,发现Clinichip试验是一种有前途的新实验室方法,用于对致癌性HPV进行基因分型

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号